This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Folkow, B. Articles by Wallin, B. G. Search for Related Content PubMed PubMed Citation Articles by Folkow, B. Articles by Wallin, B. G.

Hypertension, Vol 5, 399-403, Copyright © 1983 by American Heart Association

ARTICLES

Measurements of plasma norepinephrine concentrations in human primary hypertension. A word of caution on their applicability for assessing neurogenic contributions

B Folkow, GF Di Bona, P Hjemdahl, PH Toren and BG Wallin

The relationship between plasma levels of norepinephrine (NE) and sympathetic neural activity is discussed with special reference to human primary hypertension. Since sympathetic discharge is differentiated, neural activity to a given target organ will contribute variably to plasma NE levels in different situations. Hemodynamically, early primary hypertension is often characterized by a mild defense reaction-like pattern with signs of increased sympathetic activity to the heart and vasoconstriction in the renal and splanchnic vascular beds. Although important hemodynamically, these organs seem to be of less importance as contributors to peripheral plasma NE levels. In contrast, muscle sympathetic activity and muscle vascular resistance is unchanged or reduced. Since this organ mass contributes importantly to plasma NE levels, especially in peripheral venous blood, it is not surprising that most patients with primary hypertension have normal NE levels. It is concluded that NE concentrations in forearm or mixed venous blood are unreliable indicators of sympathetic neural contributions to essential hypertension, tending to underestimate this element, and that regional measurements of NE overflow are needed for a reliable analysis.

This article has been cited by other articles:

				G. Grassi, G. Seravalle, F. Q. Trevano, R. Dell'Oro, G. Bolla, C. Cuspidi, F. Arenare, and G. Mancia Neurogenic Abnormalities in Masked Hypertension Hypertension, September 1, 2007; 50(3): 537 - 542. [Abstract] [Full Text] [PDF]

				G. Grassi, G. Seravalle, F. Quarti-Trevano, F. Scopelliti, R. Dell'Oro, G. Bolla, and G. Mancia Excessive Sympathetic Activation in Heart Failure With Obesity and Metabolic Syndrome: Characteristics and Mechanisms Hypertension, March 1, 2007; 49(3): 535 - 541. [Abstract] [Full Text] [PDF]

				P. P. Jones, R. E. Van Pelt, D. G. Johnson, and D. R. Seals Role of Sympathetic Neural Activation in Age- and Habitual Exercise-Related Differences in the Thermic Effect of Food J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5138 - 5144. [Abstract] [Full Text] [PDF]

				D. P. Damron, I. M. Bernstein, R. E. Shapiro, and A. Schonberg Uterine Blood Flow Response to Alpha-Adrenergic Blockade in Nulligravid Women of Reproductive Age Reproductive Sciences, September 1, 2004; 11(6): 388 - 392. [Abstract] [PDF]

				A. Kamiya, D. Michikami, S. Iwase, J. Hayano, T. Kawada, M. Sugimachi, and K. Sunagawa {alpha}-Adrenergic vascular responsiveness to sympathetic nerve activity is intact after head-down bed rest in humans Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2004; 286(1): R151 - R157. [Abstract] [Full Text]

				K. Leineweber, S. Klapproth, A. Beilfuss, R.-E. Silber, G. Heusch, T. Philipp, and O.-E. Brodde Unchanged G-protein-coupled receptor kinase activity in the aging human heart J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1487 - 1492. [Abstract] [Full Text] [PDF]

				G. Grassi, G. Seravalle, C. Turri, G. Bolla, and G. Mancia Short-Versus Long-Term Effects of Different Dihydropyridines on Sympathetic and Baroreflex Function in Hypertension Hypertension, March 1, 2003; 41(3): 558 - 562. [Abstract] [Full Text] [PDF]

				K. Leineweber, T. Wangemann, C. Giessler, H. Bruck, S. Dhein, M. Kostelka, F.-W. Mohr, R.-E. Silber, and O.-E. Brodde Age-dependent changes of cardiac neuronal noradrenaline reuptake transporter (uptake1) in the human heart J. Am. Coll. Cardiol., October 16, 2002; 40(8): 1459 - 1465. [Abstract] [Full Text] [PDF]

				H. P. Schobel, H. Frank, R. Naraghi, H. Geiger, E. Titz, and K. Heusser Hypertension in Patients with Neurovascular Compression Is Associated with Increased Central Sympathetic Outflow J. Am. Soc. Nephrol., January 1, 2002; 13(1): 35 - 41. [Abstract] [Full Text] [PDF]

				D. R Seals and M. D Esler Human ageing and the sympathoadrenal system J. Physiol., November 1, 2000; 528(3): 407 - 417. [Abstract] [Full Text] [PDF]

				C. Kruger, V. Landerer, C. Zugck, H. Ehmke, W. Kubler, and M. Haass The bradycardic agent zatebradine enhances baroreflex sensitivity and heart rate variability in rats early after myocardial infarction Cardiovasc Res, March 1, 2000; 45(4): 900 - 912. [Abstract] [Full Text] [PDF]

				I. J. Kopin, B. Rundqvist, P. Friberg, J. Lenders, D. S. Goldstein, and G. Eisenhofer Different relationships of spillover to release of norepinephrine in human heart, kidneys, and forearm Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1998; 275(1): R165 - R173. [Abstract] [Full Text] [PDF]

				G. Grassi, G. Seravalle, M. Colombo, G. Bolla, B. M. Cattaneo, F. Cavagnini, and G. Mancia Body Weight Reduction, Sympathetic Nerve Traffic, and Arterial Baroreflex in Obese Normotensive Humans Circulation, May 26, 1998; 97(20): 2037 - 2042. [Abstract] [Full Text] [PDF]

				R. Willenbrock, H. Stauss, M. Scheuermann, K. J. Osterziel, T. Unger, and R. Dietz Effect of chronic volume overload on baroreflex control of heart rate and sympathetic nerve activity Am J Physiol Heart Circ Physiol, December 1, 1997; 273(6): H2580 - H2585. [Abstract] [Full Text] [PDF]

				H. P. Schobel, T. Fischer, K. Heuszer, H. Geiger, and R. E. Schmieder Preeclampsia -- A State of Sympathetic Overactivity N. Engl. J. Med., November 14, 1996; 335(20): 1480 - 1485. [Abstract] [Full Text] [PDF]

				G. Grassi, G. Seravalle, B. M. Cattaneo, A. Lanfranchi, S. Vailati, C. Giannattasio, A. Del Bo, C. Sala, G. B. Bolla, M. Pozzi, et al. Sympathetic Activation and Loss of Reflex Sympathetic Control in Mild Congestive Heart Failure Circulation, December 1, 1995; 92(11): 3206 - 3211. [Abstract] [Full Text]

				G. Grassi, G. Seravalle, B. M. Cattaneo, G. B. Bolla, A. Lanfranchi, M. Colombo, C. Giannattasio, A. Brunani, F. Cavagnini, and G. Mancia Sympathetic Activation in Obese Normotensive Subjects Hypertension, April 1, 1995; 25(4): 560 - 563. [Abstract] [Full Text]

				H. Kawabe, I. Saito, C. Hasegawa, S. Nagano, and T. Saruta Circulatory and Plasma Catecholamine Responses to Mental Stress in Young Subjects with two Different Types of Hypertension Angiology, June 1, 1994; 45(6): 435 - 441. [Abstract] [PDF]

				S. Wijnands, P.C. Chang, G.J. Blauw, J. van den Krogt, R. Gieschke, M-P. Schoerlin, and P. van Brummelen Potentiation of the pressor effect of oral and intravenous tyramine during administration of the selective MAO-A inhibitor moclobemide in healthy volunteers J Psychopharmacol, January 1, 1989; 3(1): 36 - 44. [Abstract] [PDF]

				M. Bailo, C. Fiorentini, A. Folli, C. Galli, A. Loaldi, A. Maltagliati, E. Tosi, G. Tamborini, and M. D. Guazzi Changes in Systemic and Pulmonary Vascular Reactivity in Hypertension Following Nifedipine and Verapamil Angiology, September 1, 1987; 38(9): 672 - 679. [Abstract] [PDF]

				O. Kuchel, N. T. Buu, P. Larochelle, P. Hamet, and J. Genest Jr Episodic Dopamine Discharge in Paroxysmal Hypertension: Page's Syndrome Revisited Arch Intern Med, July 1, 1986; 146(7): 1315 - 1320. [Abstract] [PDF]